In 2024, Latvia reports the highest male mortality from bladder malignant neoplasms at 22.9 per 100,000 men, marking a 2.34% increase from last year. Notably, Estonia, Finland, and Japan have all recorded slight increases, while Portugal, Denmark, and Germany have witnessed declines. Notable declines are seen in Spain and Austria. The U.S. appears moderately stable with an 8.7 rate, exhibiting a slight decrease. Emerging hotspots like Brazil and Costa Rica display significant year-on-year increases. While Japan and Australia have remained relatively stable, only moderate percentage changes have been observed.
Future trends to watch include advancements in cancer treatment, increased public health initiatives, and better diagnostic capabilities, which are likely to influence mortality rates. Countries with rising rates need targeted interventions, while those with declining rates should share best practices to aid global efforts in reducing bladder cancer mortality.
Top countries in Bladder Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) Per Hundred Thousand Men, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Latvia | 22.9 | 2023 | +0.44% | +2.34% | View data |
| 2 | 2 Poland | 20.9 | 2023 | 0% | +0.68% | View data |
| 3 | 3 Croatia | 17.8 | 2023 | +0.56% | +0.056% | View data |
| 4 | 4 Slovakia | 17.1 | 2023 | +0.59% | +0.6% | View data |
| 5 | 5 Estonia | 17 | 2023 | 0% | +1.22% | View data |
| 6 | 6 Hungary | 16.8 | 2023 | -0.59% | -0.35% | View data |
| 7 | 7 Lithuania | 16.7 | 2023 | 0% | +0.24% | View data |
| 8 | 8 Greece | 16.4 | 2023 | 0% | +0.62% | View data |
| 9 | 9 Slovenia | 16.3 | 2023 | 0% | -0.84% | View data |
| 10 | 10 Romania | 15 | 2023 | 0% | +0.54% | View data |
